• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力的自然病程:一项长期随访研究。

The natural course of myasthenia gravis: a long term follow up study.

作者信息

Oosterhuis H J

机构信息

Department of Neurology, State University Groningen, The Netherlands.

出版信息

J Neurol Neurosurg Psychiatry. 1989 Oct;52(10):1121-7. doi: 10.1136/jnnp.52.10.1121.

DOI:10.1136/jnnp.52.10.1121
PMID:2795037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1031695/
Abstract

A long term follow up study is presented of 73 patients with myasthenia gravis, living in Amsterdam between 1926 and 1965. In the period 1961-65 the annual incidence was 3.1, the prevalence 53 per million. Maximum severity of the disease occurred during the first seven years after onset in 87%. Eighteen (29%) patients died, of whom eight had a thymoma (TH). Spontaneous improvement or remission occurred at any time during the follow up. At the end of the study (1985) 16 (22%) patients were in a complete clinical remission, 13 (18%) had improved considerably (3 with prednisone), 12 (16%) had improved moderately, 12 (16%) had remained unchanged and two had deteriorated. If the early deaths are excluded the outcome is similar in the early and the late onset group without TH. Patients with TH had a less favourable course. Associated autoimmune diseases were diagnosed in 25% (n = 58). Because most of these patients were treated with anticholinesterases only, the evolution of their clinical state represents the natural course of MG.

摘要

本文呈现了一项对73例重症肌无力患者的长期随访研究,这些患者于1926年至1965年间居住在阿姆斯特丹。在1961 - 1965年期间,年发病率为3.1,患病率为每百万53例。87%的患者在发病后的前七年病情最为严重。18例(29%)患者死亡,其中8例患有胸腺瘤(TH)。在随访期间的任何时候都出现了自发改善或缓解。在研究结束时(1985年),16例(22%)患者达到完全临床缓解,13例(18%)有显著改善(3例使用泼尼松),12例(16%)有中度改善,12例(16%)病情未变,2例病情恶化。如果排除早期死亡病例,早发型和晚发型且无胸腺瘤的患者组结果相似。患有胸腺瘤的患者病程较差。25%(n = 58)的患者被诊断出患有相关自身免疫性疾病。由于这些患者大多数仅接受抗胆碱酯酶治疗,他们临床状态的演变代表了重症肌无力的自然病程。

相似文献

1
The natural course of myasthenia gravis: a long term follow up study.重症肌无力的自然病程:一项长期随访研究。
J Neurol Neurosurg Psychiatry. 1989 Oct;52(10):1121-7. doi: 10.1136/jnnp.52.10.1121.
2
Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.荷兰抗肌肉特异性激酶抗体重症肌无力的流行病学
J Neurol Neurosurg Psychiatry. 2007 Apr;78(4):417-8. doi: 10.1136/jnnp.2006.102517. Epub 2006 Oct 20.
3
Myasthenia gravis in children: a longitudinal study.儿童重症肌无力:一项纵向研究。
Acta Neurol Scand. 2006 Aug;114(2):119-23. doi: 10.1111/j.1600-0404.2006.00646.x.
4
Long-term outcome of 424 childhood-onset myasthenia gravis patients.424 例儿童起病重症肌无力患者的长期预后。
J Neurol. 2015;262(4):823-30. doi: 10.1007/s00415-015-7638-2. Epub 2015 Jan 15.
5
Surgery of myasthenia gravis associated or not with thymoma: a retrospective study of 43 cases.重症肌无力合并或不合并胸腺瘤的手术治疗:43 例回顾性研究。
Heart Lung Circ. 2013 Sep;22(9):738-41. doi: 10.1016/j.hlc.2013.02.010. Epub 2013 Mar 30.
6
Eight-year follow-up of patients with myasthenia gravis after thymectomy.重症肌无力患者胸腺切除术后八年随访
Acta Neurol Scand. 2015 Feb;131(2):94-101. doi: 10.1111/ane.12289. Epub 2014 Aug 29.
7
Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.重症肌无力:对瑞典患者的长期随访研究,特别涉及胸腺组织学
J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1109-12. doi: 10.1136/jnnp.2006.109488. Epub 2007 Mar 12.
8
Myasthenia gravis in children: long-term follow-up.儿童重症肌无力:长期随访
Ann Neurol. 1983 May;13(5):504-10. doi: 10.1002/ana.410130506.
9
Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease.
Acta Neurol Scand. 1992 Aug;86(2):113-9. doi: 10.1111/j.1600-0404.1992.tb05050.x.
10
Thymectomy in juvenile myasthenia gravis.青少年重症肌无力的胸腺切除术
J Child Neurol. 1990 Jul;5(3):215-8. doi: 10.1177/088307389000500313.

引用本文的文献

1
Juvenile Ocular Myasthenia Gravis in a 3-Year-Old African Girl: A Case Report.一名3岁非洲女孩的青少年眼肌型重症肌无力:病例报告
Case Rep Ophthalmol. 2025 May 23;16(1):454-460. doi: 10.1159/000546374. eCollection 2025 Jan-Dec.
2
The role of complement in the immunopathogenesis of acetylcholine receptor antibody-positive generalized myasthenia gravis: bystander or key player?补体在乙酰胆碱受体抗体阳性全身型重症肌无力免疫发病机制中的作用:旁观者还是关键参与者?
Front Immunol. 2025 Apr 15;16:1526317. doi: 10.3389/fimmu.2025.1526317. eCollection 2025.
3
Factors associated with increased severity of generalized myasthenia gravis among patients in the United States and Europe.美国和欧洲患者中与全身型重症肌无力严重程度增加相关的因素。
Sci Rep. 2025 Apr 1;15(1):11108. doi: 10.1038/s41598-025-93464-w.
4
Factors affecting the diagnostic delay of myasthenia gravis.影响重症肌无力诊断延迟的因素。
J Neurol. 2024 Dec 12;272(1):29. doi: 10.1007/s00415-024-12807-1.
5
Optimal time for the addition of non-corticosteroid immunosuppressants in myasthenia gravis: a single-center retrospective study in China.重症肌无力中添加非皮质类固醇免疫抑制剂的最佳时机:中国一项单中心回顾性研究
Front Neurol. 2024 Nov 6;15:1474508. doi: 10.3389/fneur.2024.1474508. eCollection 2024.
6
Acute Respiratory Failure Due to Inaugural Myasthenia Crisis.首发重症肌无力危象所致急性呼吸衰竭
Cureus. 2024 Aug 29;16(8):e68090. doi: 10.7759/cureus.68090. eCollection 2024 Aug.
7
Atypical Presentations of Myasthenia Gravis as Acute Respiratory Failure: A Rare Case.重症肌无力以急性呼吸衰竭为表现的非典型病例:1例罕见病例
Cureus. 2024 Aug 23;16(8):e67635. doi: 10.7759/cureus.67635. eCollection 2024 Aug.
8
Clinical Characteristics and Treatment of Juvenile Myasthenia Gravis-A Single-Center Experience.青少年型重症肌无力的临床特征与治疗——单中心经验
Children (Basel). 2024 May 9;11(5):572. doi: 10.3390/children11050572.
9
The Clue is in the Eyes. A Case Report of Internuclear Ophthalmoplegia.线索就在眼睛里。核间性眼肌麻痹病例报告。
J Educ Teach Emerg Med. 2024 Jan 31;9(1):V1-V8. doi: 10.21980/J8DP9M. eCollection 2024 Jan.
10
The Clinical Outcome in AChR-Positive Generalized Myasthenia Gravis: A Retrospective Observational Study.乙酰胆碱受体阳性全身型重症肌无力的临床结局:一项回顾性观察研究。
Ann Indian Acad Neurol. 2023 Jul-Aug;26(4):395-400. doi: 10.4103/aian.aian_186_23. Epub 2023 Aug 25.

本文引用的文献

1
An evaluation of thymectomy in myasthenia gravis.重症肌无力胸腺切除术的评估
Brain. 1958 Mar;81(1):112-44. doi: 10.1093/brain/81.1.112.
2
The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.明尼苏达州罗切斯特市类风湿关节炎的流行病学:发病率、患病率及死亡率研究
Am J Epidemiol. 1980 Jan;111(1):87-98. doi: 10.1093/oxfordjournals.aje.a112878.
3
The natural course of myasthenia gravis and effect of therapeutic measures.重症肌无力的自然病程及治疗措施的效果。
Ann N Y Acad Sci. 1981;377:652-69. doi: 10.1111/j.1749-6632.1981.tb33764.x.
4
Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients.重症肌无力中的抗乙酰胆碱受体抗体。第1部分。与250例患者临床参数的关系。
J Neurol Sci. 1983 Mar;58(3):357-70. doi: 10.1016/0022-510x(83)90095-3.
5
Epidemiology of myasthenia gravis in Norway.挪威重症肌无力的流行病学
Acta Neurol Scand. 1984 Oct;70(4):274-84. doi: 10.1111/j.1600-0404.1984.tb00825.x.
6
Graves' disease in Olmsted County, Minnesota, 1935 through 1967.
Mayo Clin Proc. 1970 Sep;45(9):636-44.
7
Epidemiology of myasthenia gravis in Finland.
J Neurol Sci. 1969 Nov-Dec;9(3):463-78. doi: 10.1016/0022-510x(69)90090-2.
8
Neonatal myasthenia gravis: report of two cases and review of the literature.新生儿重症肌无力:两例报告及文献复习
Pediatrics. 1970 Mar;45(3):488-504.
9
Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.重症肌无力研究:1200 多名患者的二十年经验回顾
Mt Sinai J Med. 1971 Nov-Dec;38(6):497-537.
10
Neurogenic muscle involvement in myasthenia gravis. A clinical and histopathological study.重症肌无力的神经源性肌肉受累:一项临床与组织病理学研究
J Neurol Neurosurg Psychiatry. 1973 Apr;36(2):244-54. doi: 10.1136/jnnp.36.2.244.